Comparison

AggreSure ß-Amyloid (1-40), human

Item no. AS-72215
Manufacturer AnaSpec
CASRN 131438-79-4
Amount 0.25 mg
Category
Type Peptides
Format Lyophilized
Specific against other
Conjugate/Tag Unconjugated
Purity Peak Area by HPLC ≥95%
Dry ice Yes
Sequence H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias ß-Amyloid (1-40),beta-Amyloid,aggregation,aggregates,fibrillation,fibrils,oligomerization,oligomers
Shipping Condition Dry ice
Available
Manufacturer - Applications
Aggregation/Fibrillation
Manufacturer - Category
Assays Kits Group 5 / Assays Kits Group 5 / Peptides
Manufacturer - Targets
beta-amyloid, beta-amyloid (1-40)
Shipping Temperature
4 °C
Storage Conditions
Store at -20°C. Do not freeze-thaw reconstituted peptide.
Molecular Weight
4330.2
Manufacturer - Research Area
Neuroscience / Alzheimer's Disease
Description
AggreSure beta-Amyloid (1-40) peptide is pretreated and tested for aggregation using SensoLyte® ThT A?40 Aggregation kit (Cat# AS-72213). Aggregation is guaranteed. The quantity is 0.25mg net peptide.
- Alzheimer's Disease (AD) is the most common neurodegenerative disorder in elderly people. It has been demonstrated that AD has biological causes and is characterized by the presence of senile plaques and neurofibrillary tangles mainly in cerebral cortex and hippocampus brain regions. Beta-Amyloid (1-40) (A?40) and beta-Amyloid (1-42) (A?42) are the main components of the above plaques; however, other forms of beta-Amyloid peptides are also present. Both peptides are cleaved from the Amyloid Precursor Protein (APP) by ?-secretase and ?-secretase enzymes. Many studies suggest that A?42 or/and A?43 are required to initiate formation of amyloid plaques and neurofibrills that leads to the neurodegeneration, while A?40 is less neurotoxic.
Sequence One-Letter Code
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV
Detection Method
Fluorescent
Post Synthesis Coupling
No
Resuspension Condition
Reconstitute peptide in either 50mM Tris/150mM NaCl (pH 7.2) or 20mMHEPES/150mM NaCl (pH 7.2) at 0.25 mg/ml. Use water bath sonicatorto completely dissolve peptide if necessary. Do not vortex!
Usage
Research use
UNSPSC
12352202
GTIN
5400535130381

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close